Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bedrocan forte
- Development stage
- Unknown
- Lead developer
- Bedrocan International
- Modality
- Small Molecules
- Administration
- Inhalation, Oral
01
Overview
Bedrocan forte is a standardized cannabis chemovar developed by Bedrocan International as a plant-derived active pharmaceutical ingredient (API) and botanical raw material for medicinal use. Derived from the Cannabis sativa L. 'Afina' strain, it is an enhanced version of the original Bedrocan product, featuring a higher delta-9-tetrahydrocannabinol (THC) content of 25% and less than 1.0% cannabidiol (CBD). The product is manufactured under EU-GMP conditions in Denmark to ensure consistent cannabinoid and terpene profiles across batches. It is supplied as whole or cut dried flower (cannabis flos) for use in pharmaceutical compounding and research. As a botanical raw material, its therapeutic effects are primarily mediated by the interaction of THC with the endocannabinoid system, though it is intended as a starting material for various medicinal applications rather than being approved for a single specific indication.
- Brand names
- Bedrocan forte
- Other names
- Bedrocan® forteCannabis sativa L. 'Afina'
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on Bedrocan forte.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bedrocan forte.